Cargando...
Development and evaluation of isradipine via rutin-loaded coated solid–lipid nanoparticles
The objective was to develop a stable and non-compliance coated solid–lipid nanoparticles (coated SLN) using polymer (Eudragit L100) and lipoid (glycerol monostearate: soya lecithin) for partial dose reduction of isradipine [ISR; 2.5 mg by combination of bioenhancing agent (rutin; Ru) in equivalent...
Gardado en:
| Publicado en: | Interv Med Appl Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Akadémiai Kiadó
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6376350/ https://ncbi.nlm.nih.gov/pubmed/30792921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1556/1646.10.2018.45 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|